All Press Releases

단순화된 암호화 거래를 돕는 Unstoppable Domains과 Moonstake 파트너 발표

ACN Newswire

Dec 20, 2022 18:00 HKT/SGT

Crypto, Exchange

Moonstake는 Web3 생태계 전반에서 암호화 경험을 단순화하기 위해 최고의 다목적 블록체인 도메인 솔루션 Unstoppable Domains와 전략적 파트너가 되었음을 발표하게 된 것을 기쁘게 생각합니다. 새로운 통합을 통해 사용자는 이제 단일 "암호화 사용자 이름"을 사용하여 Unstoppable Domains에서 지원하는 응용 프로그램 및 서비스뿐만 아니라 다른 사람과 거래할 수 있습니다. 여러 복잡한 암호 주소 사이를 저글링하는 대신 하나의 간단한 사용자 지정 "이름"을 사용하여 Bi

단순화된 암호화 거래를 돕는 Unstoppable Domains과 Moonstake 파트너 발표

Moonstake Partners with Unstoppable Domains for Simplified Crypto Transactions

ACN Newswire

Dec 20, 2022 18:00 HKT/SGT

Crypto, Exchange

Moonstake is excited to announce we have become strategic partners with the leading multi-purpose blockchain domain solution Unstoppable Domains to simplify the crypto experience across the Web3 ecosystem. With the new integration, our users can now use a single "crypto username" to make t

Moonstake Partners with Unstoppable Domains for Simplified Crypto Transactions

Novotech 是 Biotech Showcase 2023 的金牌贊助商

Novotech Health Holdings Pte Ltd

Dec 20, 2022 15:00 HKT/SGT

BioTech

以亞太地區為中心的生物技術專家 CRO Novotech很榮幸成為 Biotech Showcase 2023 的金牌贊助商。 Novotech 首席執行官 John Moller 博士以及來自 Novotech 美國和亞太團隊的專家將出席該會議。可以通過 PartneringOne 門戶安排會議。 https://informaconnect.com/biotech-showcase/partnering/ Novotech 將分享亞太地區加快臨床試驗的優勢,生物技術公司可以利用 Novotech 龐大的患者群體、強大的本地監管知識、廣泛的站點和 KOL 網絡以及數據質量的聲譽。在亞太地區,

Novotech 是 Biotech Showcase 2023 的金牌赞助商

Novotech Health Holdings Pte Ltd

Dec 20, 2022 15:00 HKT/SGT

BioTech

以亚太地区为中心的生物技术专家 CRO Novotech很荣幸成为 Biotech Showcase 2023 的金牌赞助商。Novotech 首席执行官 John Moller 博士以及来自 Novotech 美国和亚太团队的专家将出席该会议。可以通过 PartneringOne 门户安排会议。 https://informaconnect.com/biotech-showcase/partnering/ Novotech 将分享亚太地区加快临床试验的优势,生物技术公司可以利用 Novotech 庞大的患者群体、强大的本地监管知识、广泛的站点和 KOL 网络以及数据质量的声誉。在亚太地区,N

Novotech is Gold Sponsor at Biotech Showcase 2023

Novotech Health Holdings Pte Ltd

Dec 20, 2022 11:00 HKT/SGT

BioTech

Novotech, the Asia Pacific centered biotech specialist CRO is proud to be Gold Sponsor at Biotech Showcase 2023. Novotech CEO Dr. John Moller and experts from the Novotech US and Asia Pacific teams will be attending the conference.Meetings can be scheduled via the PartneringOne portal. https://infor

田中貴金屬工業投資旨在建立日本醫療風險生態系統的風險投資基金「DMC1號投資事業有限合夥」

ACN Newswire

Dec 20, 2022 10:00 HKT/SGT

BioTech

田中貴金屬集團旗下經營製造事業的田中貴金屬工業株式會社(總公司:東京都千代田區、董事長:田中 浩一朗)宣布投資,由長谷部光泉先生(東海大學醫學部醫學科教授/慶應義塾大學醫學部客座教授/麻省理工學院/哈佛醫學院 客座教授、醫師、醫學博士、工學博士)成立的來自日本的醫療系風險投資基金「DMC(Diamond Medino Capital)1號投資事業有限合夥」。這是在日本首次嘗試由現職醫學部教授擔任代表設立的醫療系風險投資基金。田中貴金屬工業將透過這次的投資,為日本國內的醫療與保健行業的技術發展做出貢獻。投資的背景和目的田中貴金屬工業贊同本基金所提倡的「建立來自日本的醫療風險生態系統」的理念,這次

田中貴金屬工業投資旨在建立日本醫療風險生態系統的風險投資基金「DMC1號投資事業有限合夥」

田中貴金屬工業投資旨在建立日本醫療風險生態系統的風險投資基金「DMC1號投資事業有限合夥」

ACN Newswire

Dec 20, 2022 10:00 HKT/SGT

BioTech

東京, 2022年12月20日 - (亞太商訊) - 田中貴金屬集團旗下經營製造事業的田中貴金屬工業株式會社(總公司:東京都千代田區、董事長:田中 浩一朗)宣布投資,由長谷部光泉先生(東海大學醫學部醫學科教授/慶應義塾大學醫學部客座教授/麻省理工學院/哈佛醫學院 客座教授、醫師、醫學博士、工學博士)成立的來自日本的醫療系風險投資基金「DMC(Diamond Medino Capital)1號投資事業有限合夥」。這是在日本首次嘗試由現職醫學部教授擔任代表設立的醫療系風險投資基金。田中貴金屬工業將透過這次的投資,為日本國內的醫療與保健行業的技術發展做出貢獻。 投資的背景和目的 田中貴金屬工

다나까귀금속공업 일본 의료 벤처 에코 시스템 확립을 목표로 하는 벤처 캐피털 펀드 ‘DMC 1호 투자 사업 유한 책임 조합’에 출자

ACN Newswire

Dec 20, 2022 10:00 HKT/SGT

BioTech

다나까귀금속그룹의 제조 사업을 전개하는 다나까귀금속공업주식회사(본사: 도쿄도 치요다구, 대표이사 사장 집행임원: 다나까 코이치로)는, 하세베 데루미쓰 씨(도카이 대학 의학부 의학과 교수/게이오기주쿠대학 의학부 객원교수/매사추세츠 공과대학/하버드 대학 의학부 방문교수, 의사, 의학박사, 공학박사)가 조성하는 일본의 의료계 벤처 캐피털 펀드 ‘DMC(Diamond Medino Capital) 1호 투자 사업 유한 책임 조합’에 출자한 것을 발표합니다. 현역 의학부 교수가 대표를 맡고 있는 의료계 벤처 캐피털 펀드의 설립은 일본에서 처음

다나까귀금속공업 일본 의료 벤처 에코 시스템 확립을 목표로 하는 벤처 캐피털 펀드 ‘DMC 1호 투자 사업 유한 책임 조합’에 출자

다나까귀금속공업 일본 의료 벤처 에코 시스템 확립을 목표로 하는 벤처 캐피털 펀드 ‘DMC 1호 투자 사업 유한 책임 조합’에 출자

ACN Newswire

Dec 20, 2022 10:00 HKT/SGT

BioTech

도쿄, 2022년12월20일 - (ACN Newswire) - 다나까귀금속그룹의 제조 사업을 전개하는 다나까귀금속공업주식회사(본사: 도쿄도 치요다구, 대표이사 사장 집행임원: 다나까 코이치로)는, 하세베 데루미쓰 씨(도카이 대학 의학부 의학과 교수/게이오기주쿠대학 의학부 객원교수/매사추세츠 공과대학/하버드 대학 의학부 방문교수, 의사, 의학박사, 공학박사)가 조성하는 일본의 의료계 벤처 캐피털 펀드 'DMC(Diamond Medino Capital) 1호 투자 사업 유한 책임 조합'에 출자한 것을 발표합니다.

田中贵金属工业对旨在确立日本的医疗风险企业生态系统的风险投资基金“DMC1号投资事业有限责任组合”进行出资

ACN Newswire

Dec 20, 2022 10:00 HKT/SGT

BioTech

田中贵金属集团旗下经营制造事业的田中贵金属工业株式会社(总公司:东京都千代田区、执行总裁: 田中 浩一朗)宣布,对长谷部光泉先生(东海大学医学部医学科教授/庆应义塾大学医学部客座教授/麻省理工学院/哈佛大学医学部Visiting Professor、医师、医学博士、工学博士)组建的日本医疗类风险投资基金“DMC(Diamond Medino Capital)1号投资事业有限责任组合”进行了出资。设立由现任医学部教授担任代表的医疗类风险投资基金在日本属于首次尝试。田中贵金属工业将通过本次出资,为日本国内的医疗保健行业的技术发展作出贡献。出资的背景和目的田中贵金属工业赞同本基金所提出的“确立日本首

田中贵金属工业对旨在确立日本的医疗风险企业生态系统的风险投资基金“DMC1号投资事业有限责任组合”进行出资

田中贵金属工业对旨在确立日本的医疗风险企业生态系统的风险投资基金“DMC1号投资事业有限责任组合”进行出资

ACN Newswire

Dec 20, 2022 10:00 HKT/SGT

BioTech

东京, 2022年12月20日 - (亚太商讯) - 田中贵金属集团旗下经营制造事业的田中贵金属工业株式会社(总公司:东京都千代田区、执行总裁: 田中 浩一朗)宣布,对长谷部光泉先生(东海大学医学部医学科教授/庆应义塾大学医学部客座教授/麻省理工学院/哈佛大学医学部Visiting Professor、医师、医学博士、工学博士)组建的日本医疗类风险投资基金"DMC(Diamond Medino Capital)1号投资事业有限责任组合"进行了出资。设立由现任医学部教授担任代表的医疗类风险投资基金在日本属于首次尝试。田中贵金属工业将通过本次出资,为日本国内的医疗保健行业的

TANAKA Contributes to Venture Capital Fund "DMC No. 1 Investment Limited Partnership" Aiming to Establish a Medical Venture Ecosystem in Japan

ACN Newswire

Dec 20, 2022 10:00 HKT/SGT

BioTech

TOKYO, Dec 20, 2022 - (JCN Newswire) - TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which operates the TANAKA Precious Metals manufacturing business, announced today that it has made an equity contribution to the medical venture ca

AustAsia Group in The Progress of IPO: One of The Top Five Dairy Farm Operators in China with Bright Future

AustAsia Group Ltd.

Dec 20, 2022 09:35 HKT/SGT

Food & Beverage

Reproduced from Bloomberg Terminals, the dairy products increasingly become the daily necessities for the general public in the domestic market, especially in the era when the concern over health and nutrition is raised considerablely, and there are brand-new opportunities for the dairy industry to

#WBSBangkok wraps up a successful two days and breaks new grounds for web3 in 2023

ACN Newswire

Dec 19, 2022 21:54 HKT/SGT

Trade Shows

#WBSBangkok set the global web3 stage, as hundreds of industry trailblazers, thought leaders, high-net-worth investors, global media, and blockchain technologists converged together in Bangkok on 8-9 December 2022. BANGKOK, Thailand, Dec 19, 2022 - (ACN Newswire) - The 23rd edition of World Blockch

Music Licensing, Inc.(场外交易市场OTC代码:SONG)宣布投资者的重大更新:211 表备案、潜在的远期股票拆分或股息以及在纳斯达克上市的计划

Music Licensing, Inc

Dec 19, 2022 21:00 HKT/SGT

Daily Finance

Music Licensing, Inc.(场外交易市场OTC代码:SONG)是全球最大的音乐许可公司之一,Pro Music Rights 的所有者,很高兴地宣布已向 FINRA 提交新的 211 表,以恢复其专有报价资格。该公司现在正在等待 FINRA 处理该申请,并有信心完全恢复其资格。此外,一旦 FINRA 处理了新的 211 表,Music Licensing, Inc.(场外交易市场OTC代码:SONG)正在探索远期股票分割或基于股票的股息。该公司正在考虑 1:5 远期股票分割以增加流动性、收紧 买卖差价,并增加交易量。它还正在探索以与当前类别具有相同权利的新类别普通股的形式向股东

Music Licensing, Inc.(場外交易市場OTC代碼:SONG)宣布投資者的重大更新:211 表備案、潛在的遠期股票拆分或股息以及在納斯達克上市的計劃

Music Licensing, Inc

Dec 19, 2022 21:00 HKT/SGT

Daily Finance

Music Licensing, Inc.(場外交易市場OTC代碼:SONG)是全球最大的音樂許可公司之一,Pro Music Rights 的所有者,很高興地宣布已向 FINRA 提交新的 211 表,以恢復其專有報價資格。 該公司現在正在等待 FINRA 處理該申請,並有信心完全恢復其資格。此外,一旦 FINRA 處理了新的 211 表,Music Licensing, Inc.(場外交易市場OTC代碼:SONG)正在探索遠期股票分割或基於股票的股息。該公司正在考慮 1:5 遠期股票分割以增加流動性、收緊 買賣差價,並增加交易量。 它還正在探索以與當前類別具有相同權利的新類別普通股的形式向

Music Licensing, Inc. (OTC: SONG) Announces Major Updates for Investors: Form 211 Filing, Potential Forward Stock Split or Dividend, and Plans to List on Nasdaq

Music Licensing, Inc

Dec 19, 2022 21:00 HKT/SGT

Daily Finance

Music Licensing, Inc. (OTC PINK:SONG), owner of Pro Music Rights, one of the world's largest music licensing companies, is pleased to announce that a new Form 211 has been filed with FINRA to restore its proprietary quote eligibility. The company is now awaiting FINRA to process the form and is

Gelonghui Reports CMS' Successful Phase III Study of Methylthioninium Chloride Enteric-coated Sustained-release Tablets

China Medical System Holdings Ltd.

Dec 19, 2022 19:00 HKT/SGT

Healthcare & Pharm

Gelonghui released a Press Release on "China Medical System Holdings Limited's innovative product Methylthioninium Chloride Enteric-coated Sustained-release Tablets ('the Product') has obtained positive results for its Phase III clinical trial in China."This is another break

Samaiden Group Signs Agreement to Explore Cambodia Venture

Samaiden Group Bhd

Dec 19, 2022 18:00 HKT/SGT

Daily Finance

Samaiden Group Berhad (Bursa: SAMAIDEN, 0223), a clean energy solution specialist principally involved in engineering, procurement, construction, and commissioning (EPCC) of solar photovoltaic (PV) systems and power, is pleased to announce that the Group's wholly-owned subsidiary, Samaiden Sdn

Samaiden Group Signs Agreement to Explore Cambodia Venture

Heavyweights to speak as AFF opens conference year

Bank of China

Dec 19, 2022 17:30 HKT/SGT

Trade Shows

The 16th Asian Financial Forum (AFF), organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), will be held on 11 and 12 January next year in hybrid format. Themed "Accelerating Transformation: Impact - Inclusion - I

Heavyweights to speak as AFF opens conference year
PreviousPage 589Next